The Journal of Organic Chemistry
Note
21.3, 33.3, 34.9, 42.9. 69.5, 75.0, 107.7, 125.2 (2C), 126.1 (2C), 128.3
(2C), 128.4, 129.0, 129.4 (2C), 132.4, 134.7, 137.1, 141.0. Anal. Calc.
for C21H22O2: C, 82.32; H, 7.24. Found: C, 82.38; H, 7.12.
TFAA (81 μL, 0.58 mmol) in CH2Cl2 (1.2 mL) yielded after flash
chromatography (Hexane/AcOEt 8/2) 4h (22 mg, 52%): H NMR
1
(CDCl3, 300 MHz) δ 1.39−2.01 (m, 5H), 2.77 (m, 1H), 3.74 (m,
1H), 3.92 (d, J = 7.1 Hz, 1H), 4.46−4.56 (m, 1H), 5.51 (s, 1H), 5.98
(dd, J = 15.9 Hz, J = 7.4 Hz, 1H), 6.31 (d, J = 15.9 Hz, 1H), 7.06−7.36
(m, 5H); 13C NMR (CDCl3, 75 MHz) δ 31.6, 35.4, 38.0, 68.5, 73.3,
101.4, 126.2 (2C), 127.4, 128.7 (2C), 129.0, 133.6, 137.4. Anal. Calc.
for C14H16O2: C, 77.75; H, 7.46. Found: C, 77.62; H, 7.30.
General Procedure for the Preparation of Compounds 7
Using BF3·Et2O/Et3SiH. To a stirred solution of the corresponding
bicycle 4 (1.0 equiv) in anhydrous CH2Cl2 (28 mL/mmol) at −40 °C
was added dropwise BF3·Et2O (2.5 equiv) and Et3SiH (5.0 equiv)
successively. After stirring overnight, a saturated solution of NaHCO3
was added. The layers were separated, and the aqueous one was
extracted with CHCl3. The combined organic layers were dried over
MgSO4 and concentrated in vacuo. The crude product was
chromatographed on silica gel (CH2Cl2:AcOEt 95:5) to afford the
title compounds.
(2S,4S,6R)-6-Phenyl-4-((E)-styryl)tetrahydro-2H-pyran-2-yl)-
methanol 7a. Following the general procedure, reaction of 4a (19 mg,
0.07 mmol) with BF3·Et2O (20 μL, 0.16 mmol) and Et3SiH (52 μL,
0.32 mmol) in CH2Cl2 (1.8 mL) yielded after flash chromatography
(CH2Cl2:AcOEt 95:5) 7a (15 mg, 81%): 1H NMR (CDCl3, 300
MHz) δ 1.64 (d, J = 13.4 Hz, 1H), 1.76 (ddd, J = 13.4 Hz, J = 11.8 Hz,
J = 5.1 Hz, 1H), 1.85−1.92 (m, 2H), 2.88−2.96 (m, 1H), 3.54 (dd, J =
11.5 Hz, J = 7.0 Hz, 1H), 3.61 (dd, J = 11.5 Hz, J = 3.3 Hz, 1H), 3.88−
3.99 (m, 1H), 4.66 (dd, J = 9.0 Hz, J = 5.0 Hz, 1H), 6.40−6.54 (m,
2H), 7.13−7.39 (m, 10H); 13C NMR (CDCl3, 75 MHz) δ 31.6, 34.2,
38.7, 66.6, 74.0, 75.1, 126.1 (2C), 126.2 (2C), 127.5, 127.7, 128.5
(2C), 128.8 (2C), 130.9, 132.4, 137.5, 143.0. Anal. Calc. for C20H22O2:
C, 81.60; H, 7.53. Found: C, 81.71; H, 7.44.
(1S,3S,5S)-3-((E)-4-Fluorostyryl)-1-phenyl-6,8-dioxabicyclo[3.2.1]-
octane 4c. Following the general procedure, reaction of 2a (31 mg,
0.13 mmol) with trans-2-(4-fluorophenyl)vinylboronic acid 5c (42 mg,
0.25 mmol) and TFAA (52 μL, 0.38 mmol) in CH2Cl2 (0.8 mL)
yielded after flash chromatography (Hexane/AcOEt 8/2) 4c (24 mg,
61%): 1H NMR (CDCl3, 300 MHz) δ 1.69−1.88 (m, 3H), 2.10 (dd, J
= 13.4 Hz, J = 5.5 Hz, 1H), 2.92 (m, 1H), 3.96 (m, 1H), 4.05 (d, J =
7.0 Hz, 1H), 4.69−4.76 (m, 1H), 5.96 (dd, J = 15.9 Hz, J = 7.3 Hz,
1H), 6.32 (d, J = 15.9 Hz, 1H), 6.91 (t, J = 8.7 Hz, 2H), 7.16−7.36 (m,
6H), 7.45−7.52 (m, 2H); 13C NMR (CDCl3, 75 MHz) δ 33.3, 34.8,
42.8. 69.5, 75.0, 107.7, 115.4, 115.7, 125.2 (2C), 127.6, 127.7, 128.0,
128.3 (2C), 128.5, 133.2, 141.0. Anal. Calc. for C20H19FO2: C, 77.40;
H, 6.17. Found: C, 77.44; H, 6.06.
(1S,3S,5S)-3-((E)-4-Chlorostyryl)-1-phenyl-6,8-dioxabicyclo[3.2.1]-
octane 4d. Following the general procedure, reaction of 2a (30 mg,
0.12 mmol) with trans-2-(4-chlorophenyl)vinylboronic acid 5d (44
mg, 0.24 mmol) and TFAA (51 μL, 0.36 mmol) in CH2Cl2 (0.7 mL)
yielded after flash chromatography (Hexane/AcOEt 8/2) 4d (26 mg,
66%): 1H NMR (CDCl3, 300 MHz) δ 1.69−1.88 (m, 3H), 2.10 (dd, J
= 13.3 Hz, J = 5.5 Hz, 1H), 2.94 (m, 1H), 3.96 (m, 1H), 4.05 (d, J =
7.0 Hz, 1H), 4.68−4.76 (m, 1H), 6.02 (dd, J = 15.9 Hz, J = 7.3 Hz,
1H), 6.31 (dd, J = 15.9 Hz, J = 1.1 Hz, 1H), 7.14−7.36 (m, 7H), 7.45−
7.54 (m, 2H); 13C NMR (CDCl3, 75 MHz) δ 33.3, 34.7, 42.7. 69.5,
74.9, 107.7, 125.2 (2C), 127.4 (2C), 128.0, 128.3 (2C), 128.5, 128.8
(2C), 132.9, 134.2, 136.0, 140.9. Anal. Calc. for C20H19ClO2: C, 73.50;
H, 5.86. Found: C, 73.59; H, 5.79.
(1S,3S,5S)-1-Phenyl-3-((E)-4-(trifluoromethyl)styryl)-6,8-
dioxabicyclo[3.2.1]-octane 4e. Following the general procedure,
reaction of 2a (33 mg, 0.12 mmol) with trans-2-(4-
trifluoromethylphenyl)vinylboronic acid 5e (57 mg, 0.27 mmol) and
TFAA (56 μL, 0.40 mmol) in CH2Cl2 (0.8 mL) yielded after flash
(2S,4S,6R)-4-((E)-4-Methylstyryl)-6-phenyltetrahydro-2H-pyran-2-
yl)methanol 7b. Following the general procedure, reaction of 4b (21
mg, 0.07 mmol) with BF3·Et2O (22 μL, 0.17 mmol) and Et3SiH (56
μL, 0.35 mmol) in CH2Cl2 (2.0 mL) yielded after flash
1
chromatography (Hexane/AcOEt 8/2) 4e (32 mg, 66%): H NMR
(CDCl3, 300 MHz) δ 1.71−1.91 (m, 3H), 2.12 (dd, J = 13.3 Hz, J =
5.4 Hz, 1H), 2.98 (m, 1H), 3.97 (m, 1H), 4.06 (d, J = 7.0 Hz, 1H),
4.70−4.79 (m, 1H), 6.15 (dd, J = 15.9 Hz, J = 7.2 Hz, 1H), 6.39 (d, J =
15.9 Hz, 1H), 7.16−7.39 (m, 5H), 7.44−7.55 (m, 4H); 13C NMR
(CDCl3, 75 MHz) δ 33.4, 34.6, 42.6. 69.5, 74.9, 107.7, 125.2 (2C),
125.6, 125.7, 126.4 (2C), 128.0, 128.4 (2C), 128.5, 136.2, 140.9. Anal.
Calc. for C20H19F3O2: C, 69.99; H, 5.31. Found: C, 70.06; H, 5.42.
(1S,3S,5S)-3-((E)-2-([1,1′-Biphenyl]-4-yl)vinyl)-1-phenyl-6,8-
dioxabicyclo[3.2.1]-octane 4f. Following the general procedure,
reaction of 2a (27 mg, 0.11 mmol) with trans-2-(4-biphenyl)-
vinylboronic acid 5f (49 mg, 0.22 mmol) and TFAA (46 μL, 0.33
mmol) in CH2Cl2 (0.6 mL) yielded after flash chromatography
(Hexane/AcOEt 8/2) 4f (24 mg, 59%): 1H NMR (CDCl3, 300 MHz)
δ 1.71−1.91 (m, 3H), 2.13 (dd, J = 13.5 Hz, J = 5.5 Hz, 1H), 2.96 (m,
1H), 3.97 (m, 1H), 4.07 (d, J = 6.9 Hz, 1H), 4.70−4.77 (m, 1H), 6.09
(dd, J = 15.9 Hz, J = 7.3 Hz, 1H), 6.40 (d, J = 15.9 Hz, 1H), 7.15−7.59
(m, 14H); 13C NMR (CDCl3, 75 MHz) δ 33.4, 34.8, 42.8. 69.5, 75.0,
107.7, 125.3 (2C), 126.6 (2C), 127.0 (2C), 127.4 (3C), 128.3 (2C),
128.5, 128.8, 128.9 (2C), 133.6, 136.5, 140.2, 140.9, 141.0. Anal. Calc.
for C26H24O2: C, 84.75; H, 6.57. Found: C, 84.82; H, 6.62.
(1R,3S,5S)-1-Methyl-3-((E)-styryl)-6,8-dioxabicyclo[3.2.1]octane
4g. Following the general procedure, reaction of 2b (29 mg, 0.16
mmol) with potassium trans-β-styryltrifluoroborate 5i (66 mg, 0.31
mmol) and TFAA (65 μL, 0.47 mmol) in CH2Cl2 (0.9 mL) yielded
after flash chromatography (Hexane/AcOEt 8/2) 4g (26 mg, 71%):
1H NMR (CDCl3, 300 MHz) δ 1.41 (s, 3H), 1.43−1.55 (m, 2H),
1.58−1.70 (m, 1H), 1.82 (dd, J = 13.4 Hz, J = 5.6 Hz, 1H), 2.76 (m,
1H), 3.78−3.90 (m, 2H), 4.49−4.58 (m, 1H), 5.98 (dd, J = 15.9 Hz, J
= 7.4 Hz, 1H), 6.32 (d, J = 15.9 Hz, 1H), 7.06−7.38 (m, 5H); 13C
NMR (CDCl3, 75 MHz) δ 24.4, 33.0, 34.8, 42.0. 69.2, 74.6, 107.0,
126.2 (2C), 127.3, 128.7 (2C), 129.0, 133.7, 137.5. Anal. Calc. for
C15H18O2: C, 78.23; H, 7.88. Found: C, 78.31; H, 7.95.
1
chromatography (CH2Cl2:AcOEt 95:5) 7b (16 mg, 77%): H NMR
(CDCl3, 300 MHz) δ 1.63 (d, J = 13.5 Hz, 1H), 1.75 (ddd, J = 13.5
Hz, J = 12.0 Hz, J = 5.1 Hz, 1H), 1.84−1.90 (m, 2H), 2.28 (s, 3H),
2.88−2.94 (m, 1H), 3.54 (dd, J = 11.5 Hz, J = 6.9 Hz, 1H), 3.61 (dd, J
= 11.5 Hz, J = 3.2 Hz, 1H), 3.88−3.99 (m, 1H), 4.66 (dd, J = 9.2 Hz, J
= 5.0 Hz, 1H), 6.40−6.45 (m, 2H), 7.03−7.34 (m, 9H); 13C NMR
(CDCl3, 75 MHz) δ 21.3, 31.7, 34.2, 38.7, 66.7, 74.0, 75.1, 126.0 (2C),
126.1 (2C), 127.6, 128.5 (2C), 129.5 (2C), 130.7, 131.3, 134.7, 137.3,
143.0. Anal. Calc. for C21H24O2: C, 81.78; H, 7.84. Found: C, 81.88;
H, 7.71.
(2S,4S,6R)-4-((E)-4-Fluorostyryl)-6-phenyltetrahydro-2H-pyran-2-
yl)methanol 7c. Following the general procedure, reaction of 4c (27
mg, 0.09 mmol) with BF3·Et2O (26 μL, 0.21 mmol) and Et3SiH (70
μL, 0.43 mmol) in CH2Cl2 (2.4 mL) yielded after flash
1
chromatography (CH2Cl2:AcOEt 95:5) 7c (19 mg, 71%): H NMR
(CDCl3, 300 MHz) δ 1.62 (d, J = 13.4 Hz, 1H), 1.75 (ddd, J = 13.4
Hz, J = 12.0 Hz, J = 5.2 Hz, 1H), 1.84−1.92 (m, 2H), 2.86−2.94 (m,
1H), 3.54 (dd, J = 11.3 Hz, J = 6.9 Hz, 1H), 3.61 (dd, J = 11.3 Hz, J =
2.3 Hz, 1H), 3.86−3.97 (m, 1H), 4.65 (t, J = 6.3 Hz, 1H), 6.33−6.48
(m, 2H), 6.96 (t, J = 8.5 Hz, 2H), 7.15−7.36 (m, 7H); 13C NMR
(CDCl3, 75 MHz) δ 31.6, 34.2, 38.6, 66.6, 74.0, 75.1, 115.5, 115.8,
126.1 (2C), 127.6, 127.6, 127.7, 128.5 (2C), 129.7, 132.1, 132.2, 133.6,
133.7, 142.9, 160.7, 164.0. Anal. Calc. for C20H21FO2: C, 76.90; H,
6.78. Found: C, 76.81; H, 6.91.
(2S,4S,6R)-4-((E)-4-Chlorostyryl)-6-phenyltetrahydro-2H-pyran-2-
yl)methanol 7d. Following the general procedure, reaction of 4d (21
mg, 0.06 mmol) with BF3·Et2O (20 μL, 0.16 mmol) and Et3SiH (52
μL, 0.32 mmol) in CH2Cl2 (1.8 mL) yielded after flash
1
chromatography (CH2Cl2:AcOEt 95:5) 7d (16 mg, 77%): H NMR
(CDCl3, 300 MHz) δ 1.63 (d, J = 13.4 Hz, 1H), 1.76 (ddd, J = 13.4
Hz, J = 12.4 Hz, J = 5.3 Hz, 1H), 1.85−1.92 (m, 2H), 2.86−2.96 (m,
1H), 3.48−3.68 (m, 2H), 3.85−4.02 (m, 1H), 4.64 (t, J = 6.6 Hz, 1H),
6.35−6.52 (m, 2H), 7.04−7.36 (m, 9H); 13C NMR (CDCl3, 75 MHz)
δ 31.5, 34.2, 38.5, 66.6, 74.0, 75.1, 126.1 (2C), 127.4 (3C), 127.7,
(1R,3S,5S)-3-((E)-Styryl)-6,8-dioxabicyclo[3.2.1]octane 4h. Follow-
ing the general procedure, reaction of 2c (33 mg, 0.19 mmol) with
potassium trans-β-styryltrifluoroborate 5i (82 mg, 0.39 mmol) and
12828
dx.doi.org/10.1021/jo402262m | J. Org. Chem. 2013, 78, 12825−12830